D. Final Panel. Out of 400,024 distinct Medicaid enrollees between 2006 and 2012, our panel initially contains 85,377 individuals who received at least one opioid prescription or injection in that period. We exclude 500 individuals who received a recovery prescription before their initial opioid prescription or injection, since this indicates they may have been seeking treatment for an opioid use disorder. We exclude 4,109 individuals with an adverse outcome prior to their initial opioid prescription or injection, since we assume they were already receiving opioids from another source, such as through private insurance before enrolling in Medicaid. Our final panel includes 80,768 individuals. Table S1 shows the incidence of adverse outcomes among these individuals by baseline characteristics.
Variable Construction
We construct variables that summarize information known in the 12 months prior to the individual's initial prescription.
Using the demographics from the integrated RI 360 database (8) , we construct variables for (modal) age, sex, race, marital status, body mass index, and median income and fraction below the federal povery line in the home Census block group. Using DHS data, we construct variables for household size and new births in the household, and monthly payments for the Supplemental Nutrition Assistance Program (SNAP), the Temporary Assistance for Needy Families (TANF), the General Public Assistance (GPA), the Child Care Assistance Program (CCAP), and State Supplemental Payment portions of Supplemental Security Income benefits. Using DLT data, we construct indicators for sector of work derived from the first two digits of industry codes assigned according to the North American Industry Classification System (NAICS); monthly payments for Temporary Disability Insurance (TDI) and Unemployment Insurance (UI); and quarterly wage history, including average quarterly wages and variance, the number of employers and the number of hours worked (for hourly employees); the monthly unemployment rate in Rhode Island; and the annual national unemployment rate for two-digit NAICS industries that the individual has worked in. Using DOC data, we construct indicators for charges, seven categories of sentencing, and commitments and releases from prison. Using police data, we construct variables for arrests; the number of car crashes involved and injured in; and the number of and total fines for citations.
The largest set of variables comes from the Medicaid data. These include indicators for enrollment eligibility categories, plan type, and payer codes; number of claims and total bill and payment amounts for all claims and for Emergency Department claims; indicators for prescriptions in 262 drug categories from the AHFS Pharmacologic/Therapeutic Classification; * and topic models summarizing the concatenated text descriptions for all of the individual's ICD-9 diagnosis codes and HCPCS procedure codes. We also include summary counts of the number of distinct diseases using the Clinical Classifications Software (9) , of distinct chronic conditions using the Chronic Condition Indicators (10) , and of distinct procedure codes.
A. Topic Modeling. We construct the topic models using a technique called non-negative matrix factorization (NMF), which is commonly used in text analysis to discover latent topic structure in documents (11) . In this application, we treat each individual's concatenated text descriptions of diagnosis and procedure codes as a document to learn the latent topic structure across individuals' health histories. Our topic models summarize 80,768 documents comprised of 16,367 distinct words from the code descriptions, after removing 173 uninformative words using a stopword list. The total corpus consists of over 20.5 million words.
NMF works by factorizing the non-negative d × w matrix of the documents' word frequencies into non-negative matrices d × t and t × w, where d is the number of documents, w is the number of distinct words, and t is the number of topics. We apply a term frequency-inverse document frequency (TF-IDF) transformation to the d × w matrix to reweight the word frequencies by their overall frequencies in the entire corpus, which is common practice when implementing NMF. The d × t matrix represents the weighting of topics for each document, and the t × w matrix represents the weighting of words for each topic. We summarize each topic using the 10 words with the greatest frequency in the t × w matrix.
Because the number of topics t is not known a priori, we tune this parameter by finding the t with the best out-of-sample area under the operating-receiver characteristic curve (AUC) in a logistic regression that includes only the topic model variables. We use only the training set for this tuning, and further subdivide it in half into topic training and topic validation sets. We consider an increasing number of topics and terminate the tuning procedure when the AUC does not improve by more than 0.001. The tuning achieves AUCs on the topic validation set of 0.663 for 10 topics, 0.670 for 20 topics, 0.684 for 50 topics, 0.685 for 100 topics. Therefore, we select the model with 50 topics for the final variables.
B. Low-Dosage Opioids.
Within the prescription drug categories, there is a category for opiate agonists. By construction of our panel, no individuals should have previously received an opioid prescription. However, the opiate agonist category includes 152 drugs that were not identified in the 4,175 opioid drugs from our historical NDC directory, and which are listed in Table S3 . These drugs either contain an opioid ingredient at a lower amount than the minimum thresholds defined by the Washington State prescribing guidelines, or contain an ingredient not identified in those guidelines (e.g., "opium"). Therefore, the opiate agonist variable indicates that the individual received a drug that was not likely for initiating opioid therapy, but nonetheless contains a small amount of an opioid ingredient. Most of these drugs are over-the-counter cough syrups or painkillers combined with small amounts of an opioid ingredient. Of the 152, there are eight that are not present in the historical NDC directory, possibly because they were on the market for a short enough time that they do not occur in any of the available historical snapshots of the NDC directory. * AHFS ® Pharmacologic/Therapeutic Classification © used with permission. © 2019, the American Society of Health-System Pharmacists, Inc. (ASHP). The Data is a part of the AHFS Drug Information ® ; ASHP is not responsible for the accuracy of transpositions from the original context. C. Tensors. For our neural network models, we construct tensors of monthly values for a given variable for each of the individuals in our panel in the 12 months prior to the individual's initial prescription. Missing values are imputed using mean values from the training population.
The DHS tensor includes 13 variables for demographics (age and indicators for sex, race, and Spanish or Portuguese as a primary language) and monthly payments for the Supplemental Nutrition Assistance Program (SNAP), the Temporary Assistance for Needy Families (TANF), the General Public Assistance (GPA), the Child Care Assistance Program (CCAP), and State Supplemental Payment portions of Supplemental Security Income benefits.
The DLT tensor includes 31 variables for indicators for sector of work derived from the first two digits of industry codes assigned according to the North American Industry Classification System (NAICS); monthly payments for Temporary Disability Insurance (TDI) and Unemployment Insurance (UI); and quarterly wage history, including wage amount, the number of employers and the number of hours worked (for hourly employees).
The DOC tensor includes 16 variables for demographics (age and indicators for sex, race, Spanish as a primary language), and indicators for charges, seven categories of sentencing, and commitments and releases from prison.
The Medicaid tensor includes 683 variables for demographics (age and indicators for sex, race, and Spanish or Portuguese as a primary language); indicators for eligibility categories, plan type, and payer codes at each month of enrollment; number of claims and total bill and payment amounts for all claims and for Emergency Department claims; the number of prescriptions in each of 265 categories from the AHFS Pharmacologic/Therapeutic Classification; and indicators for ICD-9 diagnosis codes and HCPCS procedure codes for all codes that are correlated >0.02 with any adverse outcome in the training population.
The police tensor includes 42 variables for demographics (age and indicators for sex and officer-observed race); indicators for all arrests, DUI arrests, and domestic-offense arrests; the number of car crashes involved and injured in; the number of and total fines for citations; and the spatio-temporal intensity of calls for service in the individual's home Census block group for 29 categories of calls.
Finally, we construct an integrated tensor including all of the 785 variables from the DHS, DLT, DOC, Medicaid, and police tensors. The dimension of this integrated tensor are 70,153 individuals x 12 months x 785 variables.
Models
We estimate a range of predictive models using modern machine learning algorithms, which vary in both their complexity and interpretability. For example, a class of models called "regularized regression models" estimate standard linear models, but search over many potential explanatory variables, potentially more explanatory variables than available data observations, to maximize out-of-sample predictive fit and minimize overfitting. Like ordinary least squares or logistic models, the model results are easy to interpret, but the complexity is limited to functions of variables the researcher specifies in advance. At the other extreme are artificial neural network models where the algorithm searches over non-linear transformations of layers of local linear regressions. The increased complexity allows the algorithm to search for arbitrary non-linearities and interactions between variables, but at a cost of greatly reducing the interpretability of the model (e.g., it is difficult to simply measure which variables contribute most to predictive fit).
A. Regularized Regression. For our regularized regression, we use an algorithm called Bootstrap Least Absolute Shrinkage and Selection Operator (BOLASSO) (12) . This algorithm is a generalization of the popular LASSO algorithm which is able to consistently identify a model even when predictors are highly correlated. The BOLASSO selects the predictors with non-zero coefficients that appear in at least 90% of bootstrapped LASSO models.
Following convention, we use BOLASSO to select the variables from among 560 variables which are persistently the strongest predictors of future adverse opioid outcomes, and we present results from a second-stage logistic regression of an indicator for future adverse outcomes on these selected variables, to describe the predictive power of each variabe. Exhibit A6 lists the variables selected by the BOLASSO as occuring with a non-zero coefficient in more than 90 of the 100 LASSO bootstrap replicates, along with the regression results from the second-stage logistic regression. In addition to the second-stage logistic regression, we also construct a regression ensemble model that averages the predictions of all 100 bootstrap replicates in the BOLASSO.
We fit each LASSO bootstrap replicate on the training set using a regularized logistic regression implementation called the gamma LASSO, which was developed specifically to address the challenges of modeling sparse, high-dimensional data (13) . Since a predictive model fits idiosyncratic noise through increased complexity in the model's structure, machine learning techniques commonly penalize complexity in the models they produce through a process called regularization. We tune the regularization parameters for the gamma LASSO model through a parameter search over gamma values in [0, 1, 10] and a path of 100 lambda values, and we select the model with the best area under the receiver-operating characteristic curve (AUC) on the validation set. Regularization helps prevent overfitting to the training data and thus improves out-of-sample fit. We are primarily interested in out-of-sample performance since our goal is to use the model to inform successful policy interventions, which require making predictions on new observations (14) .
B. Neural Networks.
We train a neural network model for each tensor using the Python package Keras (15) , which provides an interface to the TensorFlow library (16) . Specifically, we train a recurrent neural network (RNN), since RNNs have the ability to model temporal patterns in the input data. We input our training data into a two-layer network of 12x12 Long Short-Term Memory (LSTM) (17) units with the tanh activation function. We input the last LSTM layer into a dense layer that applies a sigmoid activation function to the weighted sum of the 10 inputs in order to produce a single predicted probability of adverse outcome. We employ regularization prior to each layer in the form of a dropout factor of 0.25, which causes a random deactivation of units within the layer during training with a fixed probability of 0.25 (18) .
The neural networks are optimized to minimize the binary cross-entropy, also known as log-loss, on the training data. We use the Adam optimization algorithm (19) , training with a batch size of 16 . We tune the model on the validation set by allowing the neural network to train for as many epochs as needed until the area under the receiver-operating curve (AUC) from predictions on the validation set does not improve by 0.001. Table S13 shows the AUC from predictions on the testing set for each data source and each individual outcome.
Estimation of Adverse Outcome Cost
In 2015, 33,091 people died from drug overdoses involving opioids (20) , and 2,375,000 individuals over the age of 12 had an opioid use disorder (21) . The U.S. Department of Transportation's Value of a Statistical Life is $10.1 million. Florence et al. (22) estimate the aggregate annual societal cost of an opioid use disorder to be $61,297 (including additional cost of health care, substance abuse treatment, lost productivity, and criminal justice activities). Weiss and Rao (23) estimate a 50 percent recovery probability after one year of medication-assisted treatment. Using these statistics, with the simplifying assumption that once an individual receives a prescription, they either overdose resulting in death, become dependent but successfully recover after one year of treatment, or continue to be dependent for ten years, we estimate a ballpark present discounted value of $450,000 for CA (see Table S4 ).
Propensity Score Models for Opioid Injection
To explore if rational addiction may drive first-time prescriptions for opioids, we examine data on adverse outcomes as a function of the patient's degree of knowledge that they are receiving an opioid. We use the fact that patients may receive opioids through epidural or intravenous injections during inpatient procedures. Under the assumption that these opioid recipients were less likely to be informed they were receiving an opioid than those receiving and filling a prescription from a physician, we would expect fewer adverse outcomes from opioids received through inpatient procedures than through prescriptions in a rational addiction framework.
In a simple comparison of means, we find the mean adverse outcome rate for those with an initial opioid through injection is 6.1 percent over the subsequent five years compared to 3.3 percent for an initial opioid through prescription (see Table S14 ). While this difference in means does not support a rational addiction model, it is likely that these two groups differ on many baseline characteristics and a comparison of means is biased.
Therefore, we estimate a propensity scoring model that makes use of the rich baseline data we have to understand and address the potential systematic differences between these two groups. First, we specify a logistic regression I = βX + for opioid-injection status I, where X is the set of variables selected by the main BOLASSO model (which excludes I) and is an error term. The propensity score is the predicted probabilitiesp from this model.
Next, we use the proposensity score to create a new sample through inverse probability of treatment weighting, with individual weights:
To evaluate the balance of the weighted sample, we individually regressed each variable that was significant in the propensity scoring LASSO model with I in both an unweighted and weighted regression (see Table S15 ). None of these variables have significant coefficients in the weighted regressions, indicating that the sample is now balanced.
Finally, we estimate the weighted logistic regressions Y = γI + ξ (see Table S5 ) and Y = ηX + θI + ζ (see Table S6 ), with weights wi and error terms ξ and ζ. The significance of the coefficients γ and θ for the opioid-injection status indicator I test whether there is a systematic difference in outcomes between those who receive an opioid prescription versus an opioid injection, flexibly controlling for baseline characteristics. We find that the coefficients are not significant and have positive point estimates.
Simulated Correlation between Policy Effectivness and Risk
Consider the scenario where the policy effictiveness rate αi for an individual i is negatively correlated with the individual's probability of a true positive T Pi, through the linear relationship αi = 1 − ρŶi, where αi ∈ [0, 1] andŶi is the predicted risk for individual i. The parameter ρ, which measures the degree of the negative correlation, lies in the range:
. Figure S3 shows the break-even cost ratio across cumulative risk deciles for selected values of ρ, using the averaged predicted risk E[Ŷi] across the individuals in the decile. In the case of no correlation (ρ = 0), the break-even cost ratio is the same as in the case α = 1 from Figure 2 . It is 0.232 for the top risk decile, which corresponds to a diversion cost of $104,400, assuming an adverse-outcome cost of $450,000.
Intermediate values of ρ have similar impacts on the break-even cost ratio as lowering the homogeneous policy effectiveness rate α. For example, ρ = 0.5 has a break-even cost ratio of 0.209 for the top risk decile, corresponding to a diversion cost of $94,050. This is similar to the break-even cost ratio of 0.221 for the homogeneous α = 0.893.
At the extreme value ρ = 4.02, which occurs for E[Ŷi] = 0.249 in the top risk decile, α = 0 and diversion is completely ineffective among the highest-risk individuals. However, it is effective for lower-risk individuals. For the second risk decile, the ratio is 0.047, which corresponds to a diverstion cost of $21,150. Under this assumption of strong negative correlation between αi and T Pi, the break-even cost ratio of the policy increases by including lower-risk individuals.
Population Estimates
To estimate population-level characteristics of Medicaid enrollees in Rhode Island, we constructed a second panel of longterm Medicaid enrollees. We included all enrollees who were enrolled for at least six out of 12 months in each of the five years between 2007 and 2011. This panel comprises 120,584 enrollees, who were enrolled with a median of 60 months (interquartile range of 59 to 60 months). Using this panel, we estimated the fraction of adverse outcomes, race/ethnicity, and median age among all enrollees and only those who received an opioid prescription, an opioid injection, both, or neither (see Table S14 ). For those with an opioid prescription, we calculated the average number of visits in the 30 days prior to the prescription, and the average distance to the five closest providers based on the Census block group of the last known home address before the prescription (see Table S8 ). * The frequency can be less than 90% for variables that were included in the post-BOLASSO as base terms of a selected interaction term. Table S8 . Population estimates of access to health care providers by minority status and adverse outcome status.
Group
Average visits in 30 days Average distance to closest five providers at the last known prior to initial opioid prescription home address prior to initial opioid prescription White Table S10 . Minimum amounts of ingredients in a drug to classify it as an opioid prescription or a recovery prescription. * Meperidine has no recommended starting dose for treatment of chronic pain because of its risk for complications in older adults; therefore, we consider any amount as evidence that the drug is an opioid.°W e consider any amount of a recovery ingredient as evidence that the drug may have been used to treat a prior opioid use disorder. S1 . Cumulative frequency of adverse outcomes over time since initial opioid prescription. Adverse outcomes are indicated by the diagnosis and procedure codes in Medicaid claims following the initial prescription. An individual may experience multiple types of adverse outcomes, and "any" is the union of the five specific outcome types. Opioid dependence is the most prevalent of the types. 
